Public Contracts Scotland

NP39724b Pomalidomide and Thalidomide

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Awarded
supplies
Scotland

This tender has closed

The submission deadline for this contract has passed. There may be more active supplies tenders from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS), and hundreds more across the UK public sector.

Key details

Region
Edinburgh
Contract value
£23,736,099ex VAT
Submissions closed
16 September 2024
Published
15 August 2024

Procurement

Submission method
Electronic Submission
Procedure type
Open procedure
CPV classifications
  • 33600000 Pharmaceutical products

What happened

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded this contract to Bristol-Myers Squibb Pharmaceuticals worth £959,680 on 19 Jan 2025.

Description

Supply of Thalidomide and Pomalidomide to NHS Scotland.

Full description

Supply of Thalidomide and Pomalidomide tablets to NHS Scotland. The Authority intends to award this as a multi supplier framework per product line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Additional information

The estimated value(s) referred to in Section II.1.5 cover the twelve (12) month contract duration and the thirty-six (36) month extension period of the framework agreement.

The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 27157. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363

Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/

A summary of the expected community benefits has been provided as follows:

It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework.

Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved.

Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.

For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/).

Awarded supplier

Supplier
Bristol-Myers Squibb Pharmaceuticals
Award value
£959,680
Award date
19 January 2025

Contact

Bid documents

Sign up free to open bid documents and download specifications directly.

Identifiers

Notice ID
rls-137-AUG512183
OCID
ocds-r6ebe6-0000774523

Explore related tenders

Other tenders from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

View all →

External ID: pcs-ocds-r6ebe6-0000774523 • Added 27 May 2026